Transfused, n =15 (13%) | Not transfused, n =103 (87%) | Pvalue | |
---|---|---|---|
Age (years) | 77 (72-81) | 63 (56-70) | 0.0002 |
Male sex (%) | 60 | 62 | 1.0 |
Diabetes (%) | 20 | 17 | 0.72 |
Current smokers (%) | 0 | 23 | 0.04 |
Smoking history (%) | 27 | 58 | 0.02 |
Cancer diagnosis (%) | 93 | 60 | 0.02 |
Preoperative immunosuppression (%) | 29 | 12 | 0.10 |
Duration of operation (minutes) | 240 (150-400) | 212 (145-296) | 0.26 |
Endoscopic surgery (%) | 13 | 29 | 0.35 |
Planned postoperative intensive care unit admission (%) | 87 | 68 | 0.22 |
ASA grade 3 or 4 (%) | 50 | 28 | 0.18 |
By surgical specialty n (%) | |||
General surgery | 0 (0) | 8 (7) | |
Upper gastrointestinal | 4 (27) | 23 (22) | |
Colorectal | 5 (33) | 44 (43) | |
HPB | 5 (33) | 25 (24) | |
HPB + colorectal | 1 (7) | 2 (2) | |
General surgery + colorectal | 0 (0) | 1 (1) | 0.65a |
Postoperative infections n (%) | 10 (66%) | 34 (33%) | 0.02 |
Inhospital death n (%) | 2 (13%) | 1 (1%) | 0.04 |